Mylan to invest $1 billion in India on capex in six years Press Trust of India Oct 1, 2019 Currently Mylan has 21 facilities and 15,000 employees working in India Multinational drug company Mylan will invest $1 billion…
Mylan and Biocon to present phase-III trastuzumab biosimilar data at ASCO annual meeting Usha Sharma Jun 6, 2016 HERITAGE study shows comparable efficacy, safety and immunogenicity to branded trastuzumab in HER2-positive metastatic breast…
Mylan launches Gilead Sciences’ Sovaldi tablets in India Usha Sharma May 4, 2015 Sovaldi is indicated for the treatment of chronic hepatitis C infection, a blood-borne infectious disease
Mylan signs exclusive agreement with Gilead Sciences Usha Sharma Feb 25, 2015 Under the agreement Mylan will distribute Sovaldi and Harvoni in India
Mylan to acquire Famy Care to create women’s healthcare franchise Usha Sharma Feb 4, 2015 This transaction especially complements Mylan’s pending acquisition of Abbott’s non-US developed markets speciality and branded…